Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...

In the rapidly evolving arena of regenerative science, two peptides – BPC‑157 (Body Protection Compound‑157) and TB‑500 (a short‑chain analogue of thymosin β4) – have garnered increasing interest for ...

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...

NAD⁺ is a coenzyme central to redox reactions, shuttling electrons in metabolic pathways and thereby supporting ATP ...

Ableton Live 12.4 enters public beta today, bringing wireless audio streaming, updated audio effects, improved stem ...

IPG Photonics Corporation ( IPGP) Q4 2025 Earnings Call February 12, 2026 10:00 AM EST Good morning, and welcome to IPG Photonics Fourth Quarter 2025 Conference Call. Today's call is being recorded ...

The Proper Way, Lisa and the Missing Pieces, Scott Lippitt and others take on the art of a great romantic ditty.

Operating at millimetRE-wave frequencies introduces a set of engineering challenges that extend far beyond traditional radio frequency testing ...

LL-37 continues to attract scientific interest due to its unique structural characteristics and its diverse interactions within biological systems. As the only known cathelicidin-derived peptide, LL-3 ...

CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategyCompany also discusses its ...